> It's also weird to think that someone with a rare, degenerative illness should have to evaluate whether their quality or length of life is "worth" the money t

> It's also weird to think that someone with a rare, degenerative illness should have to evaluate whether their quality or length of life is "worth" the money that a specific specialist will cost. But all countries do that cost-benefit analysis all the time. Not every procedure or medication will be administered to the patient, even when those procedures and medications have been approved for use in a particular country.